21 December 2018 - Deborah Wilkes
Pharmavite, Alliance Pharma and RB have all recently announced people changes.
New chief executive for MegaFood
US-based Pharmavite has appointed Andy Dahlen as chief executive officer of its MegaFood subsidiary, which is backed by the slogan "Fresh from farm to tablet".
Dahlen joins from Beech-Nut Nutrition where he was vice-president, marketing.
He replaces Robert Craven who is taking on an innovation and industry advisory role for Pharmavite. Craven will work closely with Tobe Cohen, chief science, technology and innovation officer at Pharmavite.
Vitamins, minerals and supplements (VMS) specialist Pharmavite is a subsidiary of Japan's Otsuka Pharmaceutical Co.
Two new non-executive directors for Alliance
UK-based Alliance Pharma has appointed Jo Le Couilliard and Richard Jones as independent non-executive directors.
Le Couilliard spent almost 20 years at GlaxoSmithKline where her roles included senior vice president and area head for the Asia-Pacific region. She left in June 2018 to focus on non-executive roles, and is now a non-executive director of Cello Health and Circassia Pharmaceuticals.
Jones is chief financial officer of Mereo BioPharma Group, a clinical stage biopharmaceutical company focused on rare diseases. Before that, he was chief financial officer of Shield Therapeutics.
Board member steps down at RB
RB has announced that André Lacroix is stepping down from its Board on 31 December 2018.
Lacroix, who has been a member of the Board for a decade, is senior independent director, chair of the Audit Committee and member of the Nomination Committee.
The UK-based company has appointed Nicandro Durante as senior independent director and Andrew Bonfield as chair of the Audit Committee with effect from 1 January 2019. They will both join the Nomination Committee.
Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions
CLICK HERE TO FIND OUT MORE